CLDF supports a wide range of projects, including clinical and laboratory-based research, lately moving into social research which looks at topics such as how to improve quality of life.
- (-) Remove Information on drugs and diseases filter Information on drugs and diseases
- (-) Remove Liver filter Liver
- (-) Remove Guinea Pig filter Guinea Pig
- (-) Remove Portals and Websites filter Portals and Websites
- (-) Remove Other Resources filter Other Resources
Discipline tool
The Foundation for Liver Research UK was established in 1974 to develop and extend research into diseases of the human liver and to enhance medical research generally.
General Database Information
The website is maintained by Norecopa. It covers all Three Rs, is in English and free of charge.
The EURL ECVAM DataBase service on ALternative Methods (DB-ALM).
The aim of "InVitroJobs" is to enable researchers to access this branch of research more easily. Alongside the job search portal, the site maintains an up-to-date list of research groups active in the development of animal-free techniques. The primary aims of this list are to advertise job vacancies, to provide students with the opportunity to contact these research groups directly to obtain information for thesis assignments and to promote cooperation, networking and the exchange of ideas between researchers.
AMC Tool is a programme to calculate antimicrobial consumption. It is aimed to replace the old ABC Calc tool.
These reccomendations are provided by Deutsche Forschungsgemeinschaft and are available in English. They may apply for a Three R information retrieval and the way, the retrieved information is processed and discussed in the project applications (to safeguard transparency, etc.).
A mainly government funded body which provides input to the UK’s Three Rs agenda, carries out research and provides funds for Three R research.
The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.